Selected research
Industry Research
Companion Animals Rabies Veterinary Vaccines Industry Research Report 2026
Market perspective
The global Companion Animals Rabies Veterinary Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Companion Animals Rabies Veterinary Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Companion Animals Rabies Veterinary Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Companion Animals Rabies Veterinary Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Companion Animals Rabies Veterinary Vaccines include Zoetis, Tianjin Ringpu Bio-Technology, Merck & Co., Inc., Virbac, Indian Immunologicals Ltd., Elanco, Dyntec, Ceva and BroadChem Philippines Biopharma Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Companion Animals Rabies Veterinary Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Companion Animals Rabies Veterinary Vaccines Market by Company
Zoetis
Tianjin Ringpu Bio-Technology
Merck & Co., Inc.
Virbac
Indian Immunologicals Ltd.
Elanco
Dyntec
Ceva
BroadChem Philippines Biopharma Corporation
Boehringer Ingelheim International GmbH
BiogenesisBago
Companion Animals Rabies Veterinary Vaccines Segment by Type
Inject Rabies Vaccine
Oral Rabies Vaccine
Companion Animals Rabies Veterinary Vaccines Segment by Application
Pet Hospital
Pet Shop
Others
Companion Animals Rabies Veterinary Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animals Rabies Veterinary Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animals Rabies Veterinary Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animals Rabies Veterinary Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Companion Animals Rabies Veterinary Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Companion Animals Rabies Veterinary Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Companion Animals Rabies Veterinary Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inject Rabies Vaccine
- Oral Rabies Vaccine
Applications
- Pet Hospital
- Pet Shop
- Others
Companies covered
- Zoetis
- Tianjin Ringpu Bio-Technology
- Merck & Co., Inc.
- Virbac
- Indian Immunologicals Ltd.
- Elanco
- Dyntec
- Ceva
- BroadChem Philippines Biopharma Corporation
- Boehringer Ingelheim International GmbH
- BiogenesisBago
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Companion Animals Rabies Veterinary Vaccines Market Size (2021-2032)
- 2.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales (2021-2032)
- 2.2.3 Global Companion Animals Rabies Veterinary Vaccines Market Average Price (2021-2032)
- 2.3 Companion Animals Rabies Veterinary Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inject Rabies Vaccine
- 2.3.3 Oral Rabies Vaccine
- 2.4 Companion Animals Rabies Veterinary Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pet Hospital
- 2.4.3 Pet Shop
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Companion Animals Rabies Veterinary Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Companion Animals Rabies Veterinary Vaccines Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Companion Animals Rabies Veterinary Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Companion Animals Rabies Veterinary Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Companion Animals Rabies Veterinary Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Companion Animals Rabies Veterinary Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Companion Animals Rabies Veterinary Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Companion Animals Rabies Veterinary Vaccines, Established Date
- 3.9 Global Companion Animals Rabies Veterinary Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Tianjin Ringpu Bio-Technology
- 4.2.1 Tianjin Ringpu Bio-Technology Company Information
- 4.2.2 Tianjin Ringpu Bio-Technology Business Overview
- 4.2.3 Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.2.5 Tianjin Ringpu Bio-Technology Recent Developments
- 4.3 Merck & Co., Inc.
- 4.3.1 Merck & Co., Inc. Company Information
- 4.3.2 Merck & Co., Inc. Business Overview
- 4.3.3 Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.3.5 Merck & Co., Inc. Recent Developments
- 4.4 Virbac
- 4.4.1 Virbac Company Information
- 4.4.2 Virbac Business Overview
- 4.4.3 Virbac Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Virbac Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.4.5 Virbac Recent Developments
- 4.5 Indian Immunologicals Ltd.
- 4.5.1 Indian Immunologicals Ltd. Company Information
- 4.5.2 Indian Immunologicals Ltd. Business Overview
- 4.5.3 Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.5.5 Indian Immunologicals Ltd. Recent Developments
- 4.6 Elanco
- 4.6.1 Elanco Company Information
- 4.6.2 Elanco Business Overview
- 4.6.3 Elanco Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Elanco Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.6.5 Elanco Recent Developments
- 4.7 Dyntec
- 4.7.1 Dyntec Company Information
- 4.7.2 Dyntec Business Overview
- 4.7.3 Dyntec Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dyntec Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.7.5 Dyntec Recent Developments
- 4.8 Ceva
- 4.8.1 Ceva Company Information
- 4.8.2 Ceva Business Overview
- 4.8.3 Ceva Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceva Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.8.5 Ceva Recent Developments
- 4.9 BroadChem Philippines Biopharma Corporation
- 4.9.1 BroadChem Philippines Biopharma Corporation Company Information
- 4.9.2 BroadChem Philippines Biopharma Corporation Business Overview
- 4.9.3 BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.9.5 BroadChem Philippines Biopharma Corporation Recent Developments
- 4.10 Boehringer Ingelheim International GmbH
- 4.10.1 Boehringer Ingelheim International GmbH Company Information
- 4.10.2 Boehringer Ingelheim International GmbH Business Overview
- 4.10.3 Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.10.5 Boehringer Ingelheim International GmbH Recent Developments
- 4.11 BiogenesisBago
- 4.11.1 BiogenesisBago Company Information
- 4.11.2 BiogenesisBago Business Overview
- 4.11.3 BiogenesisBago Companion Animals Rabies Veterinary Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BiogenesisBago Companion Animals Rabies Veterinary Vaccines Product Portfolio
- 4.11.5 BiogenesisBago Recent Developments
5 Global Companion Animals Rabies Veterinary Vaccines Market Scenario by Region
- 5.1 Global Companion Animals Rabies Veterinary Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2027-2032
- 5.3 Global Companion Animals Rabies Veterinary Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Companion Animals Rabies Veterinary Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Companion Animals Rabies Veterinary Vaccines Revenue by Region: 2027-2032
- 5.4 North America Companion Animals Rabies Veterinary Vaccines Market Facts & Figures by Country
- 5.4.1 North America Companion Animals Rabies Veterinary Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Companion Animals Rabies Veterinary Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Companion Animals Rabies Veterinary Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Companion Animals Rabies Veterinary Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Companion Animals Rabies Veterinary Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Companion Animals Rabies Veterinary Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Companion Animals Rabies Veterinary Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Companion Animals Rabies Veterinary Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Companion Animals Rabies Veterinary Vaccines Market Facts & Figures by Country
- 5.7.1 South America Companion Animals Rabies Veterinary Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Companion Animals Rabies Veterinary Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Companion Animals Rabies Veterinary Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Companion Animals Rabies Veterinary Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Companion Animals Rabies Veterinary Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Companion Animals Rabies Veterinary Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Companion Animals Rabies Veterinary Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Companion Animals Rabies Veterinary Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Companion Animals Rabies Veterinary Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Companion Animals Rabies Veterinary Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Companion Animals Rabies Veterinary Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Companion Animals Rabies Veterinary Vaccines Value Chain Analysis
- 8.1.1 Companion Animals Rabies Veterinary Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Companion Animals Rabies Veterinary Vaccines Production Mode & Process
- 8.2 Companion Animals Rabies Veterinary Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Companion Animals Rabies Veterinary Vaccines Distributors
- 8.2.3 Companion Animals Rabies Veterinary Vaccines Customers
9 Global Companion Animals Rabies Veterinary Vaccines Analyzing Market Dynamics
- 9.1 Companion Animals Rabies Veterinary Vaccines Industry Trends
- 9.2 Companion Animals Rabies Veterinary Vaccines Industry Drivers
- 9.3 Companion Animals Rabies Veterinary Vaccines Industry Opportunities and Challenges
- 9.4 Companion Animals Rabies Veterinary Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst